Bottom line
RXL vs TRUH: the short answer
RXL (ProShares Ultra Health Care) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 78% by weight.
TRUH is cheaper at 0.1% vs 0.95% — a difference of $85 a year per $10,000 invested.
Updated Nov 19, 2026
RXL vs TRUH side by side
| RXL | TRUH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.95% | 0.1% |
| Annual cost per $10k | $95 | $10 |
| 10-yr cost on $10k (prospectus) | $1,305 | — |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +19.7% | — |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +12.6% | — |
| Best quarter | +29.7% | — |
| Worst quarter | −28.9% | — |
| Net assets (fund) | $72.1M | $833.1K |
| Number of holdings | 70 | 60 |
| Portfolio turnover | 4% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
21 of RXL's top 25 holdings also appear in TRUH's top 25.
| Holding | RXL | TRUH |
|---|---|---|
| Eli Lilly & Co. | 12.67% | 16.56% |
| Johnson & Johnson | 7.86% | 10.67% |
| AbbVie, Inc. | 5.57% | 7.76% |
| UnitedHealth Group, Inc. | 4.98% | 6.59% |
| Merck & Co., Inc. | 4.26% | 5.54% |
| Thermo Fisher Scientific, Inc. | 2.68% | 3.25% |
| Amgen, Inc. | 2.62% | 3.39% |
| Gilead Sciences, Inc. | 2.41% | 2.74% |
| Intuitive Surgical, Inc. | 2.18% | 2.48% |
| Pfizer, Inc. | 2.15% | 2.40% |
| Abbott Laboratories | 2.15% | 2.76% |
| Bristol-Myers Squibb Co. | 1.68% | 2.05% |
| CVS Health Corp. | 1.67% | 2.31% |
| Danaher Corp. | 1.66% | 2.10% |
| Vertex Pharmaceuticals, Inc. | 1.64% | 2.21% |
Source: SEC Form N-PORT
RXL top 10
- Eli Lilly & Co. — 12.67%
- ProShares GENIUS Money Market ETF — 11.81%
- Johnson & Johnson — 7.86%
- AbbVie, Inc. — 5.57%
- UnitedHealth Group, Inc. — 4.98%
- Merck & Co., Inc. — 4.26%
- Repurchase Agreement — 2.91%
- Thermo Fisher Scientific, Inc. — 2.68%
- Amgen, Inc. — 2.62%
- Gilead Sciences, Inc. — 2.41%
TRUH top 10
- Eli Lilly & Co — 16.56%
- Johnson & Johnson — 10.67%
- AbbVie Inc — 7.76%
- UnitedHealth Group Inc — 6.59%
- Merck & Co Inc — 5.54%
- Amgen Inc — 3.39%
- Thermo Fisher Scientific Inc — 3.25%
- Abbott Laboratories — 2.76%
- Gilead Sciences Inc — 2.74%
- Intuitive Surgical Inc — 2.48%
FAQ
What is the difference between RXL and TRUH?
RXL (ProShares Ultra Health Care) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 78% by weight. TRUH is cheaper at 0.1% vs 0.95% — a difference of $85 a year per $10,000 invested.
Which is cheaper, RXL or TRUH?
TRUH has the lower expense ratio (0.1%).
Should I own both RXL and TRUH?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.